View More Recent Stories
-
atai Life Sciences (ATAI) Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
-
atai Life Sciences N.V (ATAI) PT Lowered to $10 at H.C. Wainwright
-
atai Life Sciences (ATAI) Reports In-Line Q3 EPS
-
Altimmune (ALT) Appoints Greg Weaver as CFO
-
H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
-
TD Cowen Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
-
atai Life Sciences N.V (ATAI) PT Lowered to $5 at Jefferies
-
atai Life Sciences (ATAI) Misses Q2 EPS by 20c
-
atai Life Sciences (ATAI) Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
-
TD Cowen Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
-
atai Life Sciences (ATAI) Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101

